Vir Biotechnology, Inc. VIR Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s increase (decrease) in other operating assets?
- Vir Biotechnology, Inc. (VIR) reported increase (decrease) in other operating assets of -$657K in Q1 2026.
- How has Vir Biotechnology, Inc.'s increase (decrease) in other operating assets changed year-over-year?
- Vir Biotechnology, Inc.'s increase (decrease) in other operating assets increased by 89.4% year-over-year, from -$6.2M to -$657K.
- What is the long-term trend for Vir Biotechnology, Inc.'s increase (decrease) in other operating assets?
- Over 3 years (2021 to 2025), Vir Biotechnology, Inc.'s increase (decrease) in other operating assets has grown at a 104.3% compound annual growth rate (CAGR), from $1.48M to $12.64M.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.